Skip Navigation

JNCI Journal of the National Cancer Institute 2005 97(19):1394-1395; doi:10.1093/jnci/dji310
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (5)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Longo, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Longo, D. L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 Oxford University Press

EDITORIAL

Radiation Therapy in Hodgkin Disease: Why Risk a Pyrrhic Victory?

Dan L. Longo

Correspondence to: Dan L. Longo, MD, National Institute on Aging, 5600 Nathan Shock Dr., Box 9, Baltimore, MD 21224-6825 (e-mail: longod@grc.nia.nih.gov).

The first 150 words of the full text of this article appear below.

Pyrrhus became King of Epirus in Northern Greece in 306 BC. He was a brilliant warrior and strategist; for example, he employed elephants in his attack force 60 years before Hannibal's famous use of these animals in the Second Punic War. In 280 BC, he invaded Italy and won a great battle at Heraclea but suffered enormous losses of men in his army. A few months later, in 279 BC, he won a second major battle at Asculum, again enduring severe and irreplaceable casualties. After being complimented on his success by one of his men, he is said to have responded, "Another such victory and we are undone." Thus, through the centuries the term "Pyrrhic victory" has been used to mean a conquest won at too great a cost for the victor.

In this issue of the Journal, Travis et al. (1) have studied the . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
JCOHome page
M. Crump and D. Hodgson
Secondary Breast Cancer in Hodgkin's Lymphoma Survivors
J. Clin. Oncol., September 10, 2009; 27(26): 4229 - 4231.
[Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
L. B. Travis
The Epidemiology of Second Primary Cancers
Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2020 - 2026.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
J. Yahalom
Don't Throw Out the Baby With the Bathwater: On Optimizing Cure and Reducing Toxicity in Hodgkin's Lymphoma
J. Clin. Oncol., February 1, 2006; 24(4): 544 - 548.
[Full Text] [PDF]